CCR4 and cancer: Although we demonstrate that antiproliferative activity of RNF219 is at least partially mediated by regulation of CNOT6L expression, further investigation would be required to conclude that the impact of RNF219 activity on cancer progression is mediated by the CCR4‐NOT complex.